(Q35012431)

5 August 2017

1 reference

title

Pharmacological approaches to discovery and development of new mucolytic agents (English)

1 reference

5 August 2017

Malcolm King

1

0 references

Bruce K. Rubin

series ordinal

2

object named as

Bruce K Rubin

2 references

5 August 2017

21 August 2021

author name string

Malcolm King

series ordinal

1

1 reference

21 August 2021

language of work or name

English

0 references

publication date

1 December 2002

1 reference

12458156

5 August 2017

2002

1 reference

21 August 2021

Advanced Drug Delivery Reviews

published in

2 references

5 August 2017

21 August 2021

volume

54

2 references

5 August 2017

21 August 2021

issue

11

2 references

5 August 2017

21 August 2021

page(s)

1475-1490

2 references

5 August 2017

21 August 2021

Human airway ion transport. Part one.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Regulation of secretion from mucous and serous cells in the excised ferret trachea

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Localization of muscarinic receptor subtype mRNAs in human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

On the movement of mucus in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Clearance of mucus by simulated cough.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The role of mucus gel viscosity, spinnability, and adhesive properties in clearance by simulated cough

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Respiratory mucous secretions in patients with cystic fibrosis: relationship between levels of highly sulfated mucin component and severity of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Recurrent respiratory infections in a child with fucosidosis: is the mucus too thin for effective transport?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Evidence that a peptide corresponding to the rat Muc2 C-terminus undergoes disulphide-mediated dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The structure and assembly of secreted mucins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The role of disulfide bonds in maintaining the gel structure of bronchial mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Pus, deoxyribonucleic acid, and sputum viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Improved clearability of cystic fibrosis sputum with dextran treatment in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Roles of hydration, sodium, and chloride in regulation of canine mucociliary transport system.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effects of dextran on tracheal mucociliary velocity in dogs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effects of dextran sulfate on tracheal mucociliary velocity in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Depolymerization of F-actin by deoxyribonuclease I

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Defective ATP-dependent mucin secretion by cystic fibrosis pancreatic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Anti-inflammatory effects of macrolides in lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Anti-inflammatory effects of macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900156-4

7 January 2021

10.1016/S0169-409X(02)00156-4

Identifiers

DOI

2 references

5 August 2017

21 August 2021

12458156

1 reference

12458156